医脉通(02192.HK)获富国基金增持167.15万股

Group 1 - The core point of the article is that Franklin Templeton has increased its stake in the company 医脉通 (Medlinker) by purchasing 1.6715 million shares at an average price of HKD 14.5086 per share, raising its ownership percentage from 4.86% to 5.09% [1][3] - The total investment made by Franklin Templeton in this transaction amounts to approximately HKD 24.2511 million [1] - Following this transaction, Franklin Templeton's total shareholding in 医脉通 now stands at 37.3465 million shares [1][3] Group 2 - The transaction date for the share purchase was August 27, 2025 [2][3] - The increase in shareholding reflects a strategic move by Franklin Templeton to enhance its position in the company [1]